DBRC
BMY icon

D.B. Root & Company’s Bristol-Myers Squibb BMY Stock Holding History

D.B. Root & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,934
Closed -$1.21M – 171
2023
Q2 		$1.21M Buy
18,934
+297
+2% +$19.9K 0.46% 60
2023
Q1 		$1.29M Buy
18,637
+1,068
+6% +$75.3K 0.51% 49
2022
Q4 		$1.26M Buy
17,569
+384
+2% +$29K 0.53% 44
2022
Q3 		$1.22M Sell
17,185
-553
-3% -$40.1K 0.56% 44
2022
Q2 		$1.36M Sell
17,738
-121
-0.7% -$9.22K 0.59% 41
2022
Q1 		$1.3M Buy
17,859
+442
+3% +$29.7K 0.49% 52
2021
Q4 		$1.08M Buy
17,417
+418
+2% +$24.5K 0.39% 59
2021
Q3 		$1M Buy
16,999
+224
+1% +$14.8K 0.39% 60
2021
Q2 		$1.12M Buy
16,775
+131
+0.8% +$8.54K 0.42% 54
2021
Q1 		$1.05M Sell
16,644
-99
-0.6% -$6.16K 0.41% 57
2020
Q4 		$1.04M Sell
16,743
-1,103
-6% -$67.8K 0.41% 61
2020
Q3 		$1.07M Sell
17,846
-536
-3% -$32.3K 0.43% 54
2020
Q2 		$1.08M Buy
18,382
+169
+0.9% +$10.1K 0.47% 51
2020
Q1 		$1.01M Buy
18,213
+1,489
+9% +$91K 0.51% 49
2019
Q4 		$1.07M Sell
16,724
-463
-3% -$26.5K 0.47% 61
2019
Q3 		$871K Sell
17,187
-253
-1% -$11.9K 0.41% 73
2019
Q2 		$790K Sell
17,440
-1,040
-6% -$48.4K 0.35% 81
2019
Q1 		$882K Sell
18,480
-5,584
-23% -$278K 0.38% 77
2018
Q4 		$1.25M Sell
24,064
-281
-1% -$15.1K 0.62% 44
2018
Q3 		$1.51M Sell
24,345
-333
-1% -$19.8K 0.67% 31
2018
Q2 		$1.37M Buy
24,678
+257
+1% +$13.9K 0.64% 33
2018
Q1 		$1.54M Buy
24,421
+6,920
+40% +$445K 0.82% 25
2017
Q4 		$1.07M Buy
+17,501
New +$1.09M 0.92% 30

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

D.B. Root & Company's BMY Position: Q3 2023 in Review

D.B. Root & Company sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 18,934 shares — an estimated $1.21M sold.

D.B. Root & Company first reported a position in BMY in Q4 2017 and held it in 23 quarters. The position peaked at $1.54M in Q1 2018. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • D.B. Root & Company reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • D.B. Root & Company sold 18,934 Bristol-Myers Squibb shares in Q3 2023, an estimated $1.21M.
  • D.B. Root & Company first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 23 quarters.
  • D.B. Root & Company's Bristol-Myers Squibb position peaked at $1.54M in Q1 2018.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on D.B. Root & Company's 13F filing for Q3 2023, filed 3 Nov 2023.